Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-04-30T20:30:16.202Z Has data issue: false hasContentIssue false

Chapter 35 - Common Rheumatologic Disease

from Section III - Care of the Elderly by Organ System

Published online by Cambridge University Press:  30 June 2022

By
Jason Liebowitz  and
Uzma Haque
Edited by
Jan Busby-Whitehead ,
Samuel C. Durso ,
Christine Arenson ,
Rebecca Elon ,
Mary H. Palmer  and
William Reichel
Jan Busby-Whitehead
Affiliation:
University of North Carolina, Chapel Hill
Samuel C. Durso
Affiliation:
The Johns Hopkins University, Maryland
Christine Arenson
Affiliation:
Thomas Jefferson University, Philadelphia
Rebecca Elon
Affiliation:
The Johns Hopkins University School of Medicine
Mary H. Palmer
Affiliation:
University of North Carolina, Chapel Hill
William Reichel
Affiliation:
Georgetown University Medical Center
Get access

Summary

As the population of the United States ages, rheumatologic disease is quickly becoming one of the more common diagnoses encountered in the geriatric population. According to the Centers for Disease Control and Prevention, approximately 54.4 million (22.7%) US adults had doctor-diagnosed arthritis, and 23.7 million (43.5% of those with arthritis) had arthritis-attributable activity limitations. In addition to increasing prevalence, disability associated with musculoskeletal disorders is increasing. It has also been noted that worldwide disability associated with musculoskeletal disorders has more than tripled since 2004. With this increased burden of disease, there is a necessity for these diseases to be managed with an interdisciplinary approach. Through appropriate partnership of physical therapists, occupational therapists, physiatrists, orthopedic surgeons, and pain specialists, rheumatologic disease in the elderly can be effectively managed.

Keywords

Rheumatologyarthritisnonsteroidal anti-inflammatory medications (NSAIDs)disease-modifying anti-rheumatic drugs (DMARDs)conventional and synthetic biologicstherapy
Type
Chapter
Information
Reichel's Care of the Elderly
Clinical Aspects of Aging
 , pp. 425 - 433
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barbour, KE, Helmick, CG, Boring, M, Brady, TJ. Vital signs: Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation – United States, 2013–2015. MMWR Morb Mortal Wkly Rep. 2017 (Mar. 10);66(9):246–253.Google Scholar
Murray, CJL, Vos, T, Lozano, R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2020: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2197–2223.CrossRefGoogle Scholar
Osteoarthritis. Centers for Disease Control and Prevention, 2019. www.cdc.gov/arthritis/basics/osteoarthritis.htm. Accessed on 03/02/2020.Google Scholar
Neogi, T, Zhang, Y. Epidemiology of osteoarthritis. Rheum Dis Clc of N Amer. 2013; 39(1):1–19.CrossRefGoogle ScholarPubMed
Blagojevic, M, Jinks, C, Jeffery, A, Jordan, KP. Risk factors for onset of osteoarthritis of the knee in older adults: A systematic review and meta-analysis. Osteoarthritis and Cartilage. 2010; 18(1):24–33.Google Scholar
Roddy, E, Zhang, W, Doherty, M. Prevalence and associations of hallux valgus in a primary care population. Arthritis Care Res. 2008; 59(6):857–862.Google Scholar
Villareal, DT, Chode, S, Parimi, N, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011; 364(13):1218–1229.Google Scholar
Towheed, T, Maxwell, L, Judd, M, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006 (Jan. 25);1:CD004257.Google Scholar
The Acetaminophen Hepatotoxicity Working Group. Recommendations for FDA interventions to decrease the occurrence of acetaminophen hepatotoxicity. Letter to Janet Woodcock, M.D., Feb. 26, 2008. US Department of Health and Human Services.Google Scholar
Underwood, M, Ashby, D, Cross, P, Hennessy, E, Letley, L, Martin, J, Mt-Isa, S, Parsons, S, Vickers, M, Whyte, K; TOIB study team. Advice to use topical or oral ibuprofen for chronic knee pain in older people: Randomised controlled trial and patient preference study. BMJ. 2008 (Jan. 19);336(7636):138–142.Google Scholar
Rolita, L, Spegman, A, Tang, X, Cronstein, BN. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013 (Mar.);61(3):335–340.Google Scholar
Kolasinski, SL, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020 (Feb.);72(2):220–233.Google Scholar
Bannuru, RR, Vaysbrot, EE, Sullivan, MC, McAlindon, TE. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2014 (Apr.);43(5):593–599.Google Scholar
Cross, M, et al. The global burden of rheumatoid arthritis: Estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 (Jul.);73(7):1316–1322.Google Scholar
Rasch, EK, Hirsch, R, Paulose-Ram, R, Hochberg, MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: Effect of different methods of case classification. Arthritis Rheum. 2003 (Apr.);48(4):917–926.CrossRefGoogle ScholarPubMed
Chen, CI, et al. Burden of rheumatoid arthritis among US Medicare population: Co-morbidities, health-care resource utilization and costs. Rheumatol Adv Pract. 2018; 2(1):rky005.Google Scholar
Innala, L, et al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis: A prospective study. Arthritis Res Ther. 2014 (Apr. 14);16(2):R94.Google Scholar
O’Dell, JR, Mikuls, TR, Taylor, TH, et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med. 2013; 369(4):307–318.Google Scholar
Ornetti, P, Chevillotte, H, Zerrak, A, Maillefert, JF. Anti-tumour necrosis factor-alpha therapy for rheumatoid and other inflammatory arthropathies: Update on safety in older patients. Drugs Aging. 2006; 23(11):855–860.Google Scholar
Roddy, E, Mallen, CD, Doherty, M. Gout. BMJ. 2013 (Oct. 1);347:f5648.Google Scholar
Campion, EW, Glynn, RJ, DeLabry, LO. Asymptomatic hyperuricemia: Risks and consequences in the Normative Aging Study. Am J Med. 1987 (Mar.);82(3):421–426.Google Scholar
Crofford, LJ. Use of NSAIDs in treating patients with arthritis. Arth Res Ther. 2013; 15 (supplement 3):S2.Google Scholar
Shoji, A, Yamanaka, H, Kamatani, N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004 (Jun. 15);51(3):321–325.CrossRefGoogle ScholarPubMed
Ko, TM, et al. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: National prospective cohort study. BMJ. 2015; 351:h4848.Google Scholar
FDA Drug Safety Communication. 2019. www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-increased-risk-death-gout-medicine-uloric-febuxostat. Accessed on 03/02/2020.Google Scholar
Wilkins, E, et al. Osteoarthritis and articular chondrocalcinosis in the elderly. Annals Rheum Dis. 1983; 42(3):280–284.Google Scholar
Terkeltaub, RA. Colchicine update: 2008. Sem Arthritis Rheum. 2008; 38(6):411–419.Google Scholar
Doran, MF, et al. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002 (Aug.); 29(8):1694–1697.Google Scholar
Gonzalez-Gay, MA, Vazquez-Rodriguez, TR, Lopez-Diaz, MJ, Miranda-Filloy, JA, Gonzalez-Juanatey, C, Martin, J, Llorca, J. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009 (Oct. 15); 61(10):1454–1461.CrossRefGoogle ScholarPubMed
González-Gay, MA, Rodríguez-Valverde, V, Blanco, R, Fernández-Sueiro, JL, Armona, J, Figueroa, M, Martínez-Taboada, VM. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate: A more benign syndrome. Arch Intern Med. 1997 (Feb. 10); 157(3):317–320.Google Scholar
Camellino, D, Cimmino, MA. Imaging of polymyalgia rheumatica: Indications on its pathogenesis, diagnosis and prognosis. Rheumatology (Oxford). 2012 (Jan.); 51(1):77–86.CrossRefGoogle ScholarPubMed
Dejaco, C, et al. 2015 Recommendations for the management of polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2015 (Oct.); 74(10):1799–1807.Google Scholar
Kermani, TA, Schäfer, VS, Crowson, CS, Hunder, GG, Gabriel, SE, Matteson, EL, Warrington, KJ. Increase in age at onset of giant cell arteritis: A population-based study. Ann Rheum Dis. 2010 (Apr.); 69(4):780–781.Google Scholar
Salvarani, C, Hunder, GG. Giant cell arteritis with low erythrocyte sedimentation rate: Frequency of occurrence in a population-based study. Arthritis Rheum. 2001 (Apr.); 45(2):140–145.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
Stone, JH, Tuckwell, K, Dimonaco, S, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017 (Jul. 27); 377(4):317–328.Google Scholar
Klauser, A, et al. Remitting seronegative symmetrical synovitis with pitting edema of the hands: Ultrasound, color doppler ultrasound, and magnetic resonance imaging findings. Arthritis Rheum. 2005 (Apr. 15); 53(2):226–233.Google Scholar
Moerman, RV, et al. Sjögren’s syndrome in older patients: Aetiology, diagnosis and management. Drugs Aging. 2013 (Mar.); 30(3):137–153.CrossRefGoogle ScholarPubMed
Theander, E, Henriksson, G, Ljungberg, O, Mandl, T, Manthorpe, R, Jacobsson, LT. Lymphoma and other malignancies in primary Sjögren’s syndrome: A cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006 (Jun.); 65(6):796–803.Google Scholar
Wilson, FC, et al. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheum. 2008; 35(3):445–447.Google Scholar
Greenberg, SA. Inclusion body myositis. Current Opinion Rheum. 2011; 23(6):574–578.Google Scholar
Pluk, H, van Hoeve, BJ, van Dooren Smay, H, et al. Autoantibodies to cytosolic 5’-nucleotidase 1 A in inclusion body myositis. Ann Neurol. 2013; 73:397–407.Google Scholar
Griggs, RC. The current status of treatment for inclusion body myositis. Neurology. 2006; 66(2 Suppl. 1):S30–S32.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×